HAVN Life Sciences Inc.
CSE: HAVN, 5NP.F
Company Overview
Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds.
Financial Highlights
$335,016
Revenue (ttm)
$89,693
Gross Profit (ttm)
-$0.19
Diluted EPS (ttm)
Management Team
Mr. Tim Moore
CEO & Chairman
Mr. Gordon Clissold FCGA, FCPA
CFO & Director
Ms. Jenna Pozar
Chief Operations Officer
Dr. Ivan Casselman
Chief Psychedelic Officer
Mr. Alexzander Samuelsson
Chief Research Officer
Mr. Paul More
Controller
Key Highlights
Market Capitalization
$4,373,646
Shares Outstanding
66,771,000
Shares Short (% of Float)
()
Insider Ownership
8%